18 hours ago
Casey Hoffman
Initial Post
COLLAPSE
Top of Form
Type 1 Diabetes Mellitus, Juvenile onset
In regard to DM I, it frequently occurs in childhood and affects both male and females equally. According to the authors Zaccardi, Webb, Yates, & Davies (2016), an estimated 5-15% of adults diagnosed with type 2 DM actually have type I DM or latent autoimmune diabetes of adults. Type 1 DM poses a greater genetic risk than type 2 DM. There are genetic influences that affect the triggering of islet autoimmunity and the progression of the disease process (Zaccardi, Webb, Yates, & Davies 2016). There is an overall higher prevalence of type 1 DM observed in relatives, which implies a genetic risk. It should be made known that glucose levels are frequently elevated years before the diagnosis of DM type 1 (Zaccardi, Webb, Yates, & Davies 2016). Even within the normal range, higher glucose levels are predictive of DM type 1 (Zaccardi, Webb, Yates, & Davies 2016). Glucose levels tend to have a wide fluctuation range during the progression to DM type 1.
Type II Diabetes Mellitus
In regard to DM type II, there is a defective insulin secretion from the pancreas. Those suffering from DM type II are unable to increase insulin secretion to overcome insulin resistance (Tuomi, 2005). Patients suffering from DM type II can be either insulin resistant or insulin sensitive. In DM type II, the first-phase insulin secretion is significantly impaired or lost (Tuomi, 2005). Patients suffering from DM type II will inevitably have complications from hyperglycemia due to their DM type II. As this disease progress, hyperglycemia becomes more severe and more difficult to treat.
Gestational Diabetes
In a normal pregnancy, the female patient must increase her insulin secretion by 200-250% (Kampmann, et.al., 2015). Gestational diabetes mellitus, or GDM, occurs when a pregnant woman is not able to produce an adequate insulin response to compensate for this normal insulin resistance (Kampmann, et.al., 2015). GDM is prevalent in both lean and obese females. In obese women, however, the pathophysiology is characterized by pre-pregnancy induced insulin resistance being amplified by the already elevated pre-pregnant insulin resistance level (Kampmann, et. al., 2015). Insulin resistance is one of the 4 known factors that are prominent in metabolic syndrome. In women that are lean and become pregnant, there seems to be a defect in the first-phase insulin response that contributes to the development of GDM.
Treatment of Diabetes II Mellitus and Dietary Considerations
In regard to the treatment of DM type II, the oral medication known as Metformin is the recommended first-line treatment, if there are no contraindications in the patient's medical history. Metformin falls in the drug class of biguanides, it can be used alone, in combination with a sulfonylurea, or insulin. Patients taking Metformin should be monitored for a decrease in their B12 level (Rosethal & Burcham, 2018 ...
slides CapTechTalks Webinar May 2024 Alexander Perry.pptx
18 hours agoCasey Hoffman Initial PostCOLLAPSETop of For.docx
1. 18 hours ago
Casey Hoffman
Initial Post
COLLAPSE
Top of Form
Type 1 Diabetes Mellitus, Juvenile onset
In regard to DM I, it frequently occurs in childhood and affects
both male and females equally. According to the authors
Zaccardi, Webb, Yates, & Davies (2016), an estimated 5-15% of
adults diagnosed with type 2 DM actually have type I DM or
latent autoimmune diabetes of adults. Type 1 DM poses a
greater genetic risk than type 2 DM. There are genetic
influences that affect the triggering of islet autoimmunity and
the progression of the disease process (Zaccardi, Webb, Yates,
& Davies 2016). There is an overall higher prevalence of type 1
DM observed in relatives, which implies a genetic risk. It
should be made known that glucose levels are frequently
elevated years before the diagnosis of DM type 1 (Zaccardi,
Webb, Yates, & Davies 2016). Even within the normal range,
higher glucose levels are predictive of DM type 1 (Zaccardi,
Webb, Yates, & Davies 2016). Glucose levels tend to have a
wide fluctuation range during the progression to DM type 1.
Type II Diabetes Mellitus
In regard to DM type II, there is a defective insulin secretion
from the pancreas. Those suffering from DM type II are unable
to increase insulin secretion to overcome insulin resistance
(Tuomi, 2005). Patients suffering from DM type II can be either
insulin resistant or insulin sensitive. In DM type II, the first-
phase insulin secretion is significantly impaired or lost (Tuomi,
2005). Patients suffering from DM type II will inevitably have
complications from hyperglycemia due to their DM type II. As
this disease progress, hyperglycemia becomes more severe and
more difficult to treat.
2. Gestational Diabetes
In a normal pregnancy, the female patient must increase her
insulin secretion by 200-250% (Kampmann, et.al., 2015).
Gestational diabetes mellitus, or GDM, occurs when a pregnant
woman is not able to produce an adequate insulin response to
compensate for this normal insulin resistance (Kampmann,
et.al., 2015). GDM is prevalent in both lean and obese females.
In obese women, however, the pathophysiology is characterized
by pre-pregnancy induced insulin resistance being amplified by
the already elevated pre-pregnant insulin resistance level
(Kampmann, et. al., 2015). Insulin resistance is one of the 4
known factors that are prominent in metabolic syndrome. In
women that are lean and become pregnant, there seems to be a
defect in the first-phase insulin response that contributes to the
development of GDM.
Treatment of Diabetes II Mellitus and Dietary Considerations
In regard to the treatment of DM type II, the oral medication
known as Metformin is the recommended first-line treatment, if
there are no contraindications in the patient's medical history.
Metformin falls in the drug class of biguanides, it can be used
alone, in combination with a sulfonylurea, or insulin. Patients
taking Metformin should be monitored for a decrease in their
B12 level (Rosethal & Burcham, 2018). Metformin should be
taken with meals to reduce GI side effects. Metformin should be
taken as prescribed including the appropriate dosage. If a dose
is missed, the patient should take that dose as soon as possible,
or if it is close to the next scheduled dose, the missed dose
should be skipped and scheduled dose should be taken in order
to get the patient back on schedule.
When taking Metformin, patients should avoid foods high in
fiber because Metformin levels have been found to decrease in
those who have a diet high in fiber (Kampmann, et.al., 2015).
Patients should also maintain a diet low in carbohydrates in
order to gain better control of their overall blood glucose
levels.
Short and Long Term Effects of Type II Diabetes Mellitus
3. Short term complications of DM type II include hypoglycemia
and hyperosmolar hyperglycemic non-ketonic syndrome
(HHNKS). Long term complications of DM type II include
diabetic retinopathy, kidney disease, diabetic neuropathy, and
macrovascular issues. Hypoglycemia may occur due to another
medication such as aspirin or from alcohol consumption.
HHNKS occurs when the blood glucose level is not controlled,
which then causes a cascade of electrolyte imbalances. The long
term effects of DM type II can be quite devastating, they
include blindness, kidney failure, and decreased
sensation/feeling in the extremities because of damage caused
to the nerves.
Kampmann, U., Madsen, L. R., Skajaa, G. O., Iversen, D. S.,
Moeller, N., & Ovesen, P. (2015).
Gestational diabetes: A clinical update. World journal of
diabetes, 6(8), 1065-1072.
https://doi.org/10.4239/wjd.v6.i8.1065
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s
pharmacotherapeutics for advanced practice providers. St.
Louis, MO: Elsevier.
Tuomi, T. (2005). Type 1 and Type 2 Diabetes What Do They
Have in Common? Diabetes, 54(2), 540-545.
Zaccardi, F., Webb, D. R., Yates, T., & Davies, M. J. (2016).
Pathophysiology of type 1 and type 2
diabetes mellitus: a 90-year perspective. Postgraduate
medical journal, 92(1084), 63-69.